PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $267,069 | -23.4% | 8,705 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $348,809 | -32.1% | 8,705 | -30.9% | 0.00% | -33.3% |
Q1 2023 | $514,002 | +5.7% | 12,595 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $486,293 | -27.4% | 12,595 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $670,000 | +33.7% | 12,595 | +46.5% | 0.00% | +33.3% |
Q2 2022 | $501,000 | +96.5% | 8,595 | +157.0% | 0.00% | +200.0% |
Q1 2022 | $255,000 | -75.6% | 3,345 | -80.7% | 0.00% | -75.0% |
Q4 2021 | $1,045,000 | +7.4% | 17,368 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $973,000 | -7.7% | 17,368 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $1,054,000 | – | 17,368 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |